Technical Analysis for NVSEF - Novartis Ag Basl
Grade | Last Price | % Change | Price Change |
---|---|---|---|
A | 87.0 | 0.55% | 0.4800 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Flat | Flat | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 200 DMA | Bullish | 0.00% | |
Crossed Above 50 DMA | Bullish | 0.00% | |
Cup with Handle | Other | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Gapped Up | Strength | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Up 4 Days in a Row | Strength | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.55% | |
Pocket Pivot | Bullish Swing Setup | 0.55% | |
Narrow Range Bar | Range Contraction | 0.55% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Rose Above Previous Day's High | 6 days ago |
Possible Pocket Pivot | 6 days ago |
Up 1 ATR | 6 days ago |
Up 1% | 6 days ago |
5x Volume Pace | 6 days ago |
Get a Trading Sidekick!
Novartis Ag Basl Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company's Innovative Medicines segment offers patented prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology and dermatology, respiratory, cardio-metabolic, and established medicine products. The company's Sandoz segment provides active ingredients and finished dosage forms of pharmaceuticals in cardiovascular, central nervous system, dermatology, gastrointestinal and hormonal therapy, metabolism, oncology, ophthalmic, pain, and respiratory areas; and finished dosage form anti-infective. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. The company's Alcon segment offers intraocular lenses and equipment for cataract procedures; equipment, instruments, and devices for vitreoretinal surgeries; surgical equipment and diagnostic devices for refractive surgical procedures; and devices to treat glaucoma. It also provides viscoelastics, surgical solutions, diagnostic ophthalmic products, surgical packs, and other disposable products for cataract and vitreoretinal surgery. In addition, this segment offers contact lenses and ocular health products; over-the-counter ophthalmic products; eye drops for the temporary relief of ocular itching due to allergies; vitamins for ocular health; and iLux Device, a therapeutic device used to treat meibomian gland dysfunction. Novartis AG has collaboration agreements with Xencor; Surface Oncology; Ligand Pharmaceuticals, Inc.; Amgen; University of California, Berkeley; Bristol-Myers Squibb; IBM Watson Health; Allergan plc; Science 37, Inc.; Bill & Melinda Gates Foundation; PEAR Therapeutics; Pfizer; and Conatus Pharmaceuticals Inc. The company was founded in 1895 and is headquartered in Basel, Switzerland.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Health Healthcare Biotechnology Pharmaceuticals Pain Surgery Pharmaceutical Industry In China Immunology Healthcare Products Healthcare Providers Ophthalmology Dosage Forms Active Pharmaceutical Ingredients Lenses Coma Dermatology Pharmaceutical Ingredients Antibiotic Itching Metabolism A Therapeutic Disposable Products Neuroscience Antibiotics Active Pharmaceutical Ingredient Ophthalmic Active Ingredients Dysfunction Allergies Myer Osage Contact Lens Meli Contact Lenses Dosage Form Glaucoma Ibm Pfizer Retina Surgeries Amgen Berkeley Biosimilar Disposable Product Watson Mge Cona Intraocular Lens Surgical Equipment Hepatology University Of California Medicine Products Novartis Ophthalmic Products Therapeutic Device Allergan Biotechnology Based Products Cataract Diagnostic Devices Eye Drop Hormonal Therapy Ocular Itching
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 95.0 |
52 Week Low | 78.7825 |
Average Volume | 43,123 |
200-Day Moving Average | 86.5726 |
50-Day Moving Average | 86.8378 |
20-Day Moving Average | 88.1705 |
10-Day Moving Average | 86.0510 |
Average True Range | 1.0115 |
RSI | 48.19 |
ADX | 26.37 |
+DI | 40.4012 |
-DI | 54.3841 |
Chandelier Exit (Long, 3 ATRs) | 90.5405 |
Chandelier Exit (Short, 3 ATRs) | 84.2346 |
Upper Bollinger Bands | 93.0728 |
Lower Bollinger Band | 83.2682 |
Percent B (%b) | 0.38 |
BandWidth | 11.1200 |
MACD Line | -0.6888 |
MACD Signal Line | -0.3253 |
MACD Histogram | -0.3635 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 87.0000 | ||||
Resistance 3 (R3) | 87.0000 | 87.0000 | 87.0000 | ||
Resistance 2 (R2) | 87.0000 | 87.0000 | 87.0000 | 87.0000 | |
Resistance 1 (R1) | 87.0000 | 87.0000 | 87.0000 | 87.0000 | 87.0000 |
Pivot Point | 87.0000 | 87.0000 | 87.0000 | 87.0000 | 87.0000 |
Support 1 (S1) | 87.0000 | 87.0000 | 87.0000 | 87.0000 | 87.0000 |
Support 2 (S2) | 87.0000 | 87.0000 | 87.0000 | 87.0000 | |
Support 3 (S3) | 87.0000 | 87.0000 | 87.0000 | ||
Support 4 (S4) | 87.0000 |